White paper · 2023 edition · volume I
Early Detection and Continuity of Care: Bridging Indonesia's Preventive Health Gap
Before selling a single test package, we wrote down why it mattered. This document sets out official data on where Indonesia's health spending goes, and why test results so often stop in a drawer.
- 91%
- of insurance spending treats illness
- 4,7%
- is what is left to prevent it
Ninety-one percent of national health insurance spending goes on treating illness. What is left, 4.7 percent, goes on preventing it.
Plebo White Paper 2023, citing the Ministry of Health's presentation to Commission IX of the Indonesian House of Representatives. These figures describe national spending, not Plebo's own results.
What is inside
Three parts, built from data anyone can check. Sources are official government publications and international bodies, footnoted on the page they appear.
01
A burden that keeps growing
What catastrophic illness costs Indonesia's national insurer, and why the worrying part is not the size of the number but the speed of it.
02
Anatomy of a leak
The four points where the value of a test evaporates, from results their owner cannot read to decisions that are nobody's job.
03
Notes from the field
What we see from a position between the laboratory and the person being tested. Qualitative, and we say so.
37 pages, 2023 edition, volume I. Analytical in nature, not medical or investment advice.
Download the white paper
Free, no form to fill in. Available in Indonesian and English, as PDF.
The launch
The white paper was launched on 5 July 2023 at The Ritz-Carlton, Jakarta, attended by Indonesia's Minister of Health, Budi Gunadi Sadikin. Written together with Livewell.
See the launch documentationCovered by
Start protecting your team's health with Plebo
Tell us what your company needs. We will help design the program, starting from the very first check-up.